Sign in
TerminatedNo phase

Prospective Clinical Follow-up of the Echo Bi-Metric Microplasty Stem for Total Hip Arthroplasty

Key facts

Who runs it
Zimmer Biomet
Where
Austin, Birmingham, Hampton, Nashville, San Diego, and Virginia Beach, United StatesSee the 6 sites
Trial code
Status
Terminated
People taking part
206 people enrolled
Started
20 Feb 2017
Ended
4 Dec 2024
Type of study
Observational
Treatments tested
  • Surgery
Record updated
5 February 2025
Why it stopped
Data collected up to this point has provided sufficient follow-up and will allow for a reasonable estimate of the five-year survivorship rate for the Echo Bi-Metric Microplasty stem in primary total hip arthroplasty.

Who can take part

Age
18 years to 65 years
Sex
Women and men

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Subjects are eligible for this trial if they satisfy all of the following criteria:; Patient is 18 to 65 years of age, inclusive; Patient is skeletally mature; Patient qualifies for primary unilateral or bilateral total hip arthroplasty based on physical exam and medical history including at least one of the following:; Osteoarthritis; Avascular necrosis; Rheumatoid arthritis; Correction of functional deformity; Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques; Patient has no history of previous total hip arthroplasty or arthrodesis of the affected hip joint(s); Patient is willing and able to complete scheduled follow-up evaluations as described in the Informed Consent; Patient, or the patient's legally authorized representative, has participated in the Informed Consent process and is willing and able to sign an IRB- approved informed consent

Who cannot take part

  • Subjects will be excluded from this trial if they satisfy any of the following criteria as determined by the research staff or in the judgment of the treating physician:; Patient has a total prosthetic hip replacement device (including surface replacement arthroplasty, endoprosthesis, etc.) in the affected hip joint(s); Patient is septic or has an active infection; Patient is uncooperative patient or is incapable of following directions; Patient is diagnosed with osteoporosis; Patient is diagnosed with a metabolic disorder which may impair bone formation; Patient is diagnosed with osteomalacia; Patient has distant foci of infections which may spread to the implant site

Where in United States

  • Growth OrthoAustin, United States
  • OrthoSports AssociatesBirmingham, United States
  • Tidewater OrthpaedicsHampton, United States
  • Southern Joint Replacement InstituteNashville, United States
  • University of CA - San DiegoSan Diego, United States
  • Jordan Young InstituteVirginia Beach, United States

About the trial

What the trial wants to find out

The primary objective of this study is to characterize survivorship of the Echo Bi-Metric Microplasty stem in unilateral or bilateral primary total hip arthroplasty at 5 years postoperative.

Treatments tested

  • Surgery

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
5 February 2025